Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TriSalus Life Sciences, Inc. - Common Stock
(NQ:
TLSI
)
4.070
-0.240 (-5.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
334,626
Open
4.320
Bid (Size)
2.760 (5,000)
Ask (Size)
4.070 (500)
Prev. Close
4.310
Today's Range
4.010 - 4.400
52wk Range
2.200 - 7.950
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 23, 2026
From
Pomerantz LLP
Via
GlobeNewswire
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 17, 2026
From
Schall Law
Via
GlobeNewswire
Performance
YTD
-33.3%
-33.3%
1 Month
+26.8%
+26.8%
3 Month
+2.8%
+2.8%
6 Month
-30.9%
-30.9%
1 Year
-17.9%
-17.9%
More News
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 16, 2026
From
Pomerantz LLP
Via
GlobeNewswire
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From
Schall Law
Via
GlobeNewswire
TriSalus Life Sciences (NASDAQ:TLSI) Swings to Surprise Net Profit in Q1, But Revenue Miss Tempers Outlook
↗
May 12, 2026
Via
Chartmill
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
June 10, 2026
From
TriSalus Life Sciences
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 09, 2026
From
Pomerantz LLP
Via
GlobeNewswire
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 03, 2026
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 02, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
May 20, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 20, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
May 19, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
May 19, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
In today's session, these stocks are experiencing unusual volume.
↗
May 19, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 19, 2026
Via
Chartmill
TriSalus (TLSI) Q1 2026 Earnings Transcript
↗
May 14, 2026
Via
The Motley Fool
Wednesday's session: top gainers and losers
↗
May 13, 2026
Via
Chartmill
What's going on in today's session
↗
May 13, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 13, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
May 13, 2026
Via
Chartmill
TriSalus Life Sciences Q1 Earnings Call Highlights
↗
May 12, 2026
Via
MarketBeat
Topics
Earnings
TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth
May 12, 2026
From
TriSalus Life Sciences
Via
Business Wire
Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance
May 12, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
May 04, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
April 28, 2026
From
TriSalus Life Sciences
Via
Business Wire
Frequently Asked Questions
Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
The current price of TriSalus Life Sciences, Inc. - Common Stock is 4.070
When was TriSalus Life Sciences, Inc. - Common Stock last traded?
The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 07/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
